The real issue here with PBM's, is that the same mechanisms that PBM's have to help consumers/patients save money on pharmaceuticals, are the same mechanisms that can be used to create a monopoly and increase corporate profits. Instead of doing more to reduce dr-g prices and help patients save money, CVS has decided to use Caremark to take advantage and boost company profits. Plus, intentionally steering people to use only CVS pharmacy, and squeezing independent pharmacies out of business. Cvs COULD do more to help patients instead of shareholders and private equity companies, and that will be their downfall, putting profits over patients.
4 replies (most recent on top)
@3c8 Nice propaganda, corp comms.
How are PBMs supposed to lower dr-g prices? They dont make the dr-gs and therefore dont set the prices. Candidly, if you have been listening last year Caremark changed the method for setting prices and it is very straightforward and transparent. Cost + a set markup + dispensing fee which is based on pharmacy. That means if prices are still high it is because big pharma is selling at a high price. Big pharma puts massive markups on dr-gs and are actually among the richest consistently and yet they just pretend like it is PBMs. Sorry but Caremark is not the problem and everyone needs to wake up and look at the facts.
As much as you want to blame RFK, that's not it. Being overstaffed and leaning on AI is what will lead to layoffs.
Does anyone feel that the new rules set out by RFK will lead to layoffs in the PBM?